Skip to content
Screener

McKesson MCK Medical-Surgical Solutions — Restructuring Charges

Other segment segments

Prescription Technology Solutions
$20M
North American Pharmaceutical
$16M

Similar metrics at other companies

Gentherm logo
THRMMedical Segments — Restructuring Charges
$290K+85.9%
Entravision Communications, Inc. logo
EVCMedia — Restructuring Charges
$1M
Helmerich & Payne logo
HPInternational Solutions — Restructuring Charges
$302K-75.6%
Helmerich & Payne logo
HPOffshore Solutions — Restructuring Charges
$0
Vishay Precision Group logo
VPGWeighing Solutions — Restructuring Charges
$7K-89.9%
TE Connectivity logo
TELTransportation Solutions — Restructuring Charges
$1M-97.0%

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.8%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$100.24B+9.1%
Enterprise value$98.54B-2.2%
P/E21.1×-8.0×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp
FCF margin1.4%-0.1pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The source filing: McKesson’s 10-K, filed May 8, 2026.

Filed
May 7, 2026, 8:00 PM EDT
Fiscal year
FY2026
Accession
0000927653-26-000069
(In millions)Year Ended March 31, 2026 / North American Pharmaceutical (1)Year Ended March 31, 2026 / Prescription Technology Solutions (2)Year Ended March 31, 2026 / Medical-Surgical Solutions (3)Year Ended March 31, 2026 / Corporate & Other (4)Total
Severance and employee-related costs, net$9$3$14$(1)$25
Exit and other-related costs (5)337151191
Asset impairments and accelerated depreciation1217(8)829
Total$24$20$43$158$245

Item 8. Financial Statements and Supplementary Data.

FAQ

What is McKesson's medical-surgical solutions — restructuring charges?
McKesson (MCK) reported medical-surgical solutions — restructuring charges of $10M in Q1 2026.
How has McKesson's medical-surgical solutions — restructuring charges changed year-over-year?
McKesson's medical-surgical solutions — restructuring charges decreased by 71.4% year-over-year, from $35M to $10M.
What is the long-term trend for McKesson's medical-surgical solutions — restructuring charges?
Over 4 years (2022 to 2026), McKesson's medical-surgical solutions — restructuring charges has grown at a 47.8% compound annual growth rate (CAGR), from $9M to $43M.
What does medical-surgical solutions — restructuring charges mean?
This metric aggregates the total costs associated with reorganizing the Medical-Surgical Solutions segment to improve operational efficiency or integrate acquisitions. It encompasses severance, facility closures, and other costs incurred during a formal restructuring program.

Ask your AI about McKesson's medical-surgical solutions — restructuring charges.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude